{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:23:07Z","timestamp":1772306587750,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Tuberculosis (TB) is a major public health problem, and understanding the geographic distribution of the disease is critical in planning and evaluating intervention strategies. This manuscript illustrates the application of Group-Based Trajectory Modeling (GBTM), a statistical method that analyzes the evolution of an outcome over time to identify groups with similar trajectories. Specifically, we apply GBTM to identify the evolution of the number of TB notifications over time across various geographic locations, aiming to identify groups of locations with similar trajectories. Locations sharing the same trajectory may be considered geographic TB clusters, indicating areas with similar TB notifications. We used data abstracted from clinic records in Limpopo province, South Africa, treating the clinics as a proxy for the spatial location of their respective catchment areas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data for this analysis were obtained as part of a cluster-randomized trial involving 56 clinics to evaluate two active TB patient-finding strategies in South Africa. We utilized GBTM to identify groups of clinics with similar trajectories of the number of TB patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified three trajectory groups: Groups 1, comprising 57.8% of clinics; Group 2, 33.9%; and Group 3, 8.3%. These groups accounted for 30.8%, 44.4%, and 24.8% of total TB-diagnosed patients, respectively. The estimated mean number of TB-diagnosed patients was highest in trajectory group 3 followed by trajectory group 2 across the 12\u00a0months, with no overlap in the corresponding 95% confidence intervals. The estimated mean number of TB-diagnosed patients over time was fairly constant for trajectory groups 1 and 2 with exponentiated slopes of 0.979 (95% CI: 0.950, 1.004) and 1.004 (95% CI: 0.977, 1.044), respectively. In contrast, there was a statistically significant 3.8% decrease in the number of TB patients per month for trajectory group 3 with an exponentiated slope of 0.962 (95% CI: 0.901, 0.985) per month.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>GBTM is a powerful tool for identifying geographic clusters of varying levels of TB notification when longitudinal data on the number of TB diagnoses are available. This analysis can inform the planning and evaluation of intervention strategies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-025-22083-x","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:46:24Z","timestamp":1740746784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Group-based trajectory modeling to describe the geographical distribution of tuberculosis notifications"],"prefix":"10.1186","volume":"25","author":[{"given":"Alemnew F.","family":"Dagnew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen F.","family":"Hanrahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Dowdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil A.","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limakatso","family":"Lebina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bareng A. S.","family":"Nonyane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"22083_CR1","unstructured":"WHO. Global tuberculosis report 2024. Geneva: World Health Organization; 2024."},{"key":"22083_CR2","unstructured":"van der Walt M MS, et al. The First National TB Prevalence Survey. South Africa, 2018."},{"issue":"6","key":"22083_CR3","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4269\/ajtmh.16-0427","volume":"96","author":"J Lessler","year":"2017","unstructured":"Lessler J, Azman AS, McKay HS, Moore SM. What is a Hotspot Anyway? Am J Trop Med Hyg. 2017;96(6):1270\u20133.","journal-title":"Am J Trop Med Hyg"},{"issue":"2\u20133","key":"22083_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000360229","volume":"65","author":"DS Nagin","year":"2014","unstructured":"Nagin DS. Group-based trajectory modeling: an overview. Ann Nutr Metab. 2014;65(2\u20133):205\u201310.","journal-title":"Ann Nutr Metab"},{"key":"22083_CR5","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/CLEP.S265287","volume":"12","author":"HL Nguena Nguefack","year":"2020","unstructured":"Nguena Nguefack HL, Page MG, Katz J, Choiniere M, Vanasse A, Dorais M, et al. Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches. Clin Epidemiol. 2020;12:1205\u201322.","journal-title":"Clin Epidemiol"},{"issue":"4","key":"22083_CR6","doi-asserted-by":"publisher","first-page":"e1002796","DOI":"10.1371\/journal.pmed.1002796","volume":"16","author":"CF Hanrahan","year":"2019","unstructured":"Hanrahan CF, Nonyane BAS, Mmolawa L, West NS, Siwelana T, Lebina L, et al. Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB). PLoS Med. 2019;16(4):e1002796.","journal-title":"PLoS Med"},{"key":"22083_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338.","journal-title":"Annu Rev Clin Psychol"},{"issue":"5","key":"22083_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1177\/0011000016658097","volume":"44","author":"S Frankfurt","year":"2016","unstructured":"Frankfurt S, Frazier P, Syed M, Jung KR. Using Group-Based Trajectory and Growth Mixture Modeling to Identify Classes of Change Trajectories. Couns Psychol. 2016;44(5):622\u201360.","journal-title":"Couns Psychol"},{"key":"22083_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0049124113503141","volume":"42","author":"BL Jones","year":"2012","unstructured":"Jones BL, Nagin DS. A Note on a Stata Plugin for Estimating Group-based Trajectory Models. Sociological Methods & Research. 2012;42:608\u201313.","journal-title":"Sociological Methods & Research"},{"issue":"1","key":"22083_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.20982\/tqmp.05.1.p011","volume":"5","author":"H Andruff","year":"2009","unstructured":"Andruff H, Carraro N, Thompson A, Gaudreau P, Louvet B. Latent class growth modelling: a tutorial. Tutorials in Quantitative Methods for Psychology. 2009;5(1):11\u201324.","journal-title":"Tutorials in Quantitative Methods for Psychology"},{"issue":"1","key":"22083_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/0278-6133.23.1.3","volume":"23","author":"VS Helgeson","year":"2004","unstructured":"Helgeson VS, Snyder P, Seltman H. Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol. 2004;23(1):3\u201315.","journal-title":"Health Psychol"},{"key":"22083_CR12","doi-asserted-by":"publisher","first-page":"100279","DOI":"10.1016\/j.lanepe.2021.100279","volume":"13","author":"NK Adjei","year":"2022","unstructured":"Adjei NK, Schluter DK, Straatmann VS, Melis G, Fleming KM, McGovern R, et al. Impact of poverty and family adversity on adolescent health: a multi-trajectory analysis using the UK Millennium Cohort Study. Lancet Reg Health Eur. 2022;13:100279.","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"22083_CR13","doi-asserted-by":"publisher","first-page":"e000243","DOI":"10.1136\/bmjdrc-2016-000243","volume":"4","author":"DM Shearer","year":"2016","unstructured":"Shearer DM, Thomson WM, Broadbent JM, McLean R, Poulton R, Mann J. High-risk glycated hemoglobin trajectories established by mid-20s: findings from a birth cohort study. BMJ Open Diabetes Res Care. 2016;4(1):e000243.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"22083_CR14","doi-asserted-by":"crossref","unstructured":"Chimoyi LA, Lienhardt C, Moodley N, Shete P, Churchyard GJ, Charalambous S. Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review. BMJ Glob Health. 2020;5(7):e002355.","DOI":"10.1136\/bmjgh-2020-002355"},{"issue":"2","key":"22083_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11524-018-0319-6","volume":"96","author":"E Noykhovich","year":"2019","unstructured":"Noykhovich E, Mookherji S, Roess A. The Risk of Tuberculosis among Populations Living in Slum Settings: a Systematic Review and Meta-analysis. J Urban Health. 2019;96(2):262\u201375.","journal-title":"J Urban Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22083-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22083-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22083-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T16:16:25Z","timestamp":1741364185000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22083-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22083"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22083-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the Kharitode TB trial was obtained from the Human Research Ethics Committee at the University of the Witwatersrand in South Africa (clearance number 150216). All the participants of the Kharitode TB trial (TB index patients and their contacts) provided written informed consent.The Kharitode TB trial was conducted in accordance with applicable Good Clinical Practice (GCP) guidelines and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"797"}}